We are monitoring the impact of COVID-19 on North America Sepsis Diagnostics Market Get in touch with us for detailed analysis Know More
Pulished Date April, 2021
ID: 2823
Share on
Share on

North America Sepsis Diagnostics Market Research Report – Segmented By Pathogen, Product , Technology, Method , Usability, & By Country (US, Canada and Rest of North America) - Industry Analysis on Size, Share, Trends, COVID-19 Impact & Growth Forecast (2021 to 2026)

Pulished: April, 2021
ID: 2823
Pages: 145

North America Sepsis Diagnostics Market Size (2021 to 2026)

The size of the Sepsis Diagnostics Market in North America is valued at USD 430.63 Million in 2021. This value is growing at a CAGR of 8.43%, to reach USD 645.43 Million by 2026 owing to factors such as the increase in the geriatric population in the region combined with the development of infrastructure of health care and the Increasing prevalence of cancer and diabetes in the countries of the North American region. However, lack of awareness and shortage of skilled human resources in North American areas limit the growth of the region's sepsis diagnostics market.

Factors such as the increased prevalence of sepsis, increased incidence of hospital-acquired infections, increased numbers of pneumonia cases, increased numbers of sepsis treatments, and studies related to sepsis, and improved activity are expected to accelerate the growth rate of the North American sepsis diagnostics market.

Nosocomial infections and the elevating prevalence of sepsis have led to a growing need for its early diagnosis, one of the North American sepsis diagnostic market drivers. The other significant factors driving growth in the North American sepsis diagnostics market are the increasing prevalence of different bacterial strains resistant to antibiotics, an aging population, increased healthcare awareness, and healthcare spending. Also, the growing number of surgical procedures and the number of product approvals for the diagnosis of sepsis are expected to support the North American sepsis diagnosis market's growth shortly. The high incidence of hospital infections is the main factor accelerating the North American sepsis diagnostic market's growth. 

In the United States alone, approximately 1,000,000 deaths are due to sepsis caused by hospital patients. Besides, the development of biomarkers used in clinical trials that possess specificity has significantly boosted business growth. This large number is expected to serve as an engine for market growth. An increase in cases of nosocomial infections acts as a market driver. In addition, the neonatal and geriatric population is more affected by sepsis, which adds to the market's growth rate. Molecular diagnostics is expected to dominate the North American market for sepsis diagnostics by technology during 2020-2025. Technological advancements in molecular diagnostics, coupled with the growing need for rapid and accurate results and clinicians' penchant for molecular diagnostics diagnostic techniques, are expected to drive segment growth through 2025.

According to the North American Hospital Association, postoperative blood infections increased 8%, and urinary tract infections increased by 3.6% with postoperative catheter use. Healthcare providers, nursing teams, and individual physicians and nurses are also aware of infection-related issues and have taken specific steps to prevent them. However, similar hospital infections have been observed around the world, increasing the demand for sepsis diagnosis. As a result, improved nosocomial conditions are expected to drive the North America Sepsis Diagnostics Market's overall growth during the forecast period.

The lack of standard protocols has hindered the growth of the North America Sepsis Diagnostics Market. Dearth in skilled people to operate the systems in diagnostic centers is also degrading the market's demand. The lack of a standard protocol is a significant constraint for the North American market.

The National Institutes of Health supports several studies on sepsis and evaluates various potential treatments for sepsis. The US Centers for Disease Control and Prevention (CDC) has launched the “Getting Rid of Sepsis,” an educational program designed to protect Americans from sepsis. The plan calls on healthcare professionals to educate patients, prevent infections, detect and diagnose sepsis early, and promptly treat sepsis. New technologies, combined with a better understanding of the immune system's response to premature, early-infected neonates, offer the opportunity to develop essential biomarkers to improve the early identification of this high-risk population. As a result, increased sepsis and government initiatives may drive North America Sepsis Diagnostics Market growth.

The skilled technicians for advanced technology are significant challenges in the North America Sepsis Diagnostics Market's growth.

Covid-19 impact on North America Sepsis Diagnostics market:

SARS-CoV-2, a coronavirus human has never encountered before, is responsible for hundreds of thousands of deaths in the North American region. The surfacing of new infectious agents is tragically part of the contagious disease cycle. What is not part of this cycle are the many COVID-19-related deaths that occur due to our systemic inability to use rapid diagnostic tools - something health systems have long neglected at our risk. In addition, many deaths from Covid-19 reflect deaths from sepsis, which can also be largely avoided with better diagnostic tools. Sepsis, the immune system's uncontrolled response to infection, often results in organ failure and death. In the United States alone, sepsis is responsible for more than 250,000 deaths per year and accounts for 1 in 3 deaths in hospitals.

This research report has been segmented and sub-segmented the North America Sepsis Diagnostics Market into the following categories:

By Pathogen:

  • Bacterial Sepsis    
    • Gram-Negative Bacterial Sepsis
    • Gram-Positive Bacterial Sepsis
  • Fungal Sepsis        
  • Other Pathogen Infections

By Product:

  • Instruments          
  • Blood Culture Media          
  • Assay Kits & Reagents       
  • Software  

By Technology:

  • Microbiology         
  • Molecular Diagnostics       
  • Immunoassays    
  • Flow Cytometry  
  • Other Technologies

By Method:

  • Conventional Diagnostics
  • Automated Diagnostics

By Usability:

  • Laboratory Testing              
  • Point-of-Care Testing

By Country:

  • The United States
  • Canada
  • Rest of North America

Regionally, North America was accounted for most of the market share in the global market in 2020. It can be attributed to the increasing prevalence of sepsis, increasing the incidence of nosocomial infections, and the rapid adoption of sepsis diagnostic devices: high-quality range and growing government support for sepsis research. In addition, high brand awareness, favorable reimbursement scenarios, and the presence of established players facilitate this region's dominance throughout the study period. As a result, North America is the leading regional market for the diagnosis of sepsis, followed by Europe. The presence of prominent players in these two regions is likely to remain an essential factor for the sepsis diagnostics market in these regions during the forecast period.

The U.S. Sepsis Diagnostics Market is leading the North American market while Canada is in second place. Stakeholder focuses on research projects, drug discovery, and diagnosis has helped the USA dominate the market. However, the USA is also expected to increase the fastest owing to several factors such as an increasing number of surgical procedures, a growing number of clinical studies, developing healthcare infrastructure, and the rising focus of global players in this region.

KEY MARKET PLAYERS:

A few of the prominent companies dominating the North America Sepsis Diagnostics market profiled in the report are bioMérieux SA, T2 Biosystem Inc, Cepheid, Thermo Fisher Scientific Inc., Nanosphere Inc, Abbott Laboratories, Roche Diagnostics Limited, Becton, Dickinson and Company, Bruker Corporation, and Beckman Coulter, Inc.

1.Introduction                                  

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods                          

                1.4 General Study Assumptions                

2. Research Methodology                                           

                2.1 Introduction                               

                2.2 Research Phases                      

                                2.2.1 Secondary Research           

                                2.2.2 Primary Research 

                                2.2.3 Econometric Modelling      

                                2.2.4 Expert Validation  

                2.3 Analysis Design                         

                2.4 Study Timeline                          

3. Overview                                       

                3.1 Executive Summary                

                3.2 Key Inferences                         

                3.3 Epidemology                              

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                    

                4.1 Market Drivers                          

                4.2 Market Restraints                    

                4.3 Key Challenges                         

                4.4 Current Opportunities in the Market                              

5. Market Segmentation                                              

                5.1 Pathogen                    

                                5.1.1 Introduction           

                                5.1.2 Bacterial Sepsis     

                                                5.1.2.1 Gram-Negative Bacterial Sepsis

                                                5.1.2.2 Gram-Positive Bacterial Sepsis

                                5.1.3 Fungal Sepsis         

                                5.1.4 Other Pathogen Infections              

                                5.1.5  Y-o-Y Growth Analysis, By Pathogen           

                                5.1.6  Market Attractiveness Analysis, By Pathogen         

                                5.1.7  Market Share Analysis, By Pathogen          

                5.2 Product                        

                                5.2.1 Introduction           

                                5.2.2 Instruments           

                                5.2.3 Blood Culture Media           

                                5.2.4 Assay Kits & Reagents        

                                5.2.5 Software  

                                5.2.6 Y-o-Y Growth Analysis, By Product               

                                5.2.7 Market Attractiveness Analysis, By Product             

                                5.2.8 Market Share Analysis, By Product               

                5.3 Technology                 

                                5.3.1 Introduction           

                                5.3.2 Microbiology          

                                5.3.3 Molecular Diagnostics        

                                5.3.4 Immunoassays      

                                5.3.5 Flow Cytometry    

                                5.3.6 Other Technologies             

                                5.3.7 Y-o-Y Growth Analysis, By Technology        

                                5.3.8  Market Attractiveness Analysis, By Technology     

                                5.3.9  Market Share Analysis, By Technology       

                5.4 Method                       

                                5.4.1 Introduction           

                                5.4.2 Convential Diagnostics       

                                5.4.3 Automated Diagnostics     

                                5.4.4 Y-o-Y Growth Analysis, By Method               

                                5.4.5  Market Attractiveness Analysis, By Method            

                                5.4.6  Market Share Analysis, By Method             

                5.5 Usability                       

                                5.5.1 Introduction           

                                5.5.2 Laboratory Testing               

                                5.5.3 Point-of-Care Testing         

                                5.5.4 Y-o-Y Growth Analysis, By Usability              

                                5.5.5 Market Attractiveness Analysis, By Usability            

                                5.5.6 Market Share Analysis, By Usability              

6. Geographical Analysis                                              

                6.1 Introduction                               

                                6.1.1 Regional Trends    

                                6.1.2 Impact Analysis     

                                6.1.3 Y-o-Y Growth Analysis        

                                                6.1.3.1 By Geographical Area

                                                6.1.3.2 By Pathogen

                                                6.1.3.3 By Product

                                                6.1.3.4 By Technology

                                                6.1.3.5 By Method

                                                6.1.3.6 By Usability

                                6.1.4  Market Attractiveness Analysis     

                                                6.1.4.1 By Geographical Area

                                                6.1.4.2 By Pathogen

                                                6.1.4.3 By Product

                                                6.1.4.4 By Technology

                                                6.1.4.5 By Method

                                                6.1.4.6 By Usability

                                6.1.5  Market Share Analysis      

                                                6.1.5.1 By Geographical Area

                                                6.1.5.2 By Pathogen

                                                6.1.5.3 By Product

                                                6.1.5.4 By Technology

                                                6.1.5.5 By Method

                                                6.1.5.6 By Usability

                6.2 United States                            

                6.3 Canada                         

7.Strategic Analysis                                        

                7.1 PESTLE analysis                         

                                7.1.1 Political     

                                7.1.2 Economic 

                                7.1.3 Social         

                                7.1.4 Technological         

                                7.1.5 Legal          

                                7.1.6 Environmental       

                7.2 Porter’s Five analysis                              

                                7.2.1 Bargaining Power of Suppliers        

                                7.2.2 Bargaining Power of Consumers    

                                7.2.3 Threat of New Entrants     

                                7.2.4 Threat of Substitute Products and Services              

                                7.2.5 Competitive Rivalry within the Industry     

8.Market Leaders' Analysis                                         

                8.1 bioMérieux SA                          

                                8.1.1 Overview 

                                8.1.2 Pathogen Analysis               

                                8.1.3 Financial analysis  

                                8.1.4 Recent Developments       

                                8.1.5 SWOT analysis       

                                8.1.6 Analyst View          

                8.2 T2 Biosystem Inc                      

                8.3 Cepheid                       

                8.4 Thermo Fisher Scientific Inc.                               

                8.5 Nanosphere Inc                        

                8.6 Abbott Laboratories                               

                8.7 Roche Diagnostics Limited                    

                8.8 Becton, Dickinson and Company                       

                8.9 Bruker Corporation                 

                8.10 Beckman Coulter, Inc                           

9.Competitive Landscape                                            

                9.1 Market share analysis                            

                9.2 Merger and Acquisition Analysis                       

                9.3 Agreements, collaborations and Joint Ventures                         

                9.4 New Product Launches                         

10.Market Outlook and Investment Opportunities                                          

Appendix                                           

                a) List of Tables                

                b) List of Figures                              

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis, and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
  1. North America Sepsis Diagnostics Market By Pathogen, From 2021 to 2026 (USD Million)
  2. North America Bacterial Sepsis Diagnostics Market By Region, From 2021 to 2026 (USD Million)
  3. North America Fungal Sepsis Diagnostics Market By Region, From 2021 to 2026 (USD Million)
  4. North America Other Pathogen Infections Market By Region, From 2021 to 2026 (USD Million)
  5. North America Sepsis Diagnostics Market By Products, From 2021 to 2026 (USD Million)
  6. North America Instruments Market By Region, From 2021 to 2026 (USD Million)
  7. North America Blood Culture Media Market By Region, From 2021 to 2026 (USD Million)
  8. North America Assay Kits and Reagents Market By Region, From 2021 to 2026 (USD Million)
  9. North America Software Market By Region, From 2021 to 2026 (USD Million)
  10. North America Sepsis Diagnostics Market By Technology, From 2021 to 2026 (USD Million)
  11. North America Molecular Diagnostics Market By Region, From 2021 to 2026 (USD Million)
  12. North America Microbiology Market By Region, From 2021 to 2026 (USD Million)
  13. North America Immunoassay Market By Region, From 2021 to 2026 (USD Million)
  14. North America Flow Cytometry Market By Region, From 2021 to 2026 (USD Million)
  15. North America Sepsis Diagnostics Market By Method, From 2021 to 2026 (USD Million)
  16. North America Conventional Sepsis Diagnostics Market By Region, From 2021 to 2026 (USD Million)
  17. North America Automated Sepsis Diagnostics Market By Region, From 2021 to 2026 (USD Million)
  18. North America Sepsis Diagnostics Market By Usability, From 2021 to 2026 (USD Million)
  19. North America Laboratory Testing Market By Region, From 2021 to 2026 (USD Million)
  20. North America Point-of-Care Testing Market By Region, From 2021 to 2026 (USD Million)
  21. United States Sepsis Diagnostics Market By Pathogen, From 2021 to 2026 (USD Million)
  22. United States Sepsis Diagnostics Market By Products, From 2021 to 2026 (USD Million)
  23. United States Sepsis Diagnostics Market By Technology, From 2021 to 2026 (USD Million)
  24. United States Sepsis Diagnostics Market By Method, From 2021 to 2026 (USD Million)
  25. United States Sepsis Diagnostics Market By Usability, From 2021 to 2026 (USD Million)
  26. Canada Sepsis Diagnostics Market By Pathogen, From 2021 to 2026 (USD Million)
  27. Canada Sepsis Diagnostics Market By Products, From 2021 to 2026 (USD Million)
  28. Canada Sepsis Diagnostics Market By Technology, From 2021 to 2026 (USD Million)
  29. Canada Sepsis Diagnostics Market By Method, From 2021 to 2026 (USD Million)
  30. Canada Sepsis Diagnostics Market By Usability, From 2021 to 2026 (USD Million)

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 3335

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample